Casdin Capital, LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2019$14,842,000,000
+1.8%
820,000
+10.1%
1.54%
+12.5%
Q2 2019$14,579,650,000
+150112.8%
745,000
+112.9%
1.36%
+28.0%
Q1 2019$9,706,000
+24.0%
350,0000.0%1.07%
-20.4%
Q4 2018$7,826,000
-2.2%
350,0000.0%1.34%
+37.8%
Q3 2018$8,001,000
+241.0%
350,000
+204.3%
0.97%
+196.3%
Q2 2018$2,346,000
+109.1%
115,000
+91.7%
0.33%
+66.5%
Q1 2018$1,122,00060,0000.20%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2019
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$8,936,0002.21%
Vida Ventures Advisors, LLC 770,845$1,519,0001.28%
OUP Management Co., LLC 64,000$126,0000.17%
Oasis Management Co Ltd. 280,000$552,0000.10%
Vivo Capital, LLC 370,068$729,0000.07%
AAF Wealth Management, LLC 47,501$94,0000.07%
TANG CAPITAL MANAGEMENT LLC 214,898$423,0000.06%
Temasek Holdings (Private) Ltd 5,650,996$11,132,4620.06%
Bellevue Group AG 1,622,522$3,196,0000.04%
GSA CAPITAL PARTNERS LLP 128,353$253,0000.04%
View complete list of HOMOLOGY MEDICINES INC shareholders